IRS-Protein Scaffolds and Insulin/IGF Action

Handbook of Cell Signaling: Volume 1-3

Volumn 1-3, Issue , 2003, Pages 409-419

  White, Morris F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57649131727     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012124546-7/50433-2     Document Type: Chapter

References (108)

1. M. Kasuga, F.A. Karlsson and C.R. Kahn (1982) Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215 185-187.
2. M. Kasuga, Y. Zick, D.L. Blithe, M. Crettaz and C.R. Kahn (1982) Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298 667-669.
3. M.F. White, R. Maron and C.R. Kahn (1985) Insulin rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells. Nature 318 183-186.
4. M.F. White, J.N. Livingston, J.M. Backer, V. Lauris, T.J. Dull, A. Ullrich, et al. (1988) Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54 641-649.
5. X.J. Sun, P.L. Rothenberg, C.R. Kahn, J.M. Backer, E. Araki, P.A. Wilden, et al. (1991) The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352 73-77.
6. S.E. Shoelson, S. Chatterjee, M. Chaudhuri and M.F. White (1992) YMXM motifs of IRS-1 define the substrate specificity of the insulin receptor kinase. Proc. Natl. Acad. Sci. USA 89 2027-2031.
7. X.J. Sun, D.L. Crimmings, M.G. Myers Jr., M. Miralpeix and M.F. White (1993) Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13(12), 7418-7428.
8. J.M. Backer, M.G. Myers Jr., S.E. Shoelson, D.J. Chin, X.J. Sun, M. Miralpeix, et al. (1992) Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11 3469-3479.
9. A. Ullrich, J.R. Bell, E.Y. Chen, R. Herrera, L.M. Petruzzelli, T.J. Dull, et al. (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313 756-761.
10. Y. Ebina, L. Ellis, K. Jarnagin, M. Edery, L. Graf, E. Clauser, et al. (1985) The human insulin receptor cDNA: the structural basis for hormone activated transmembrane signaling. Cell 40 747-758.
11. M.F. White, S.E. Shoelson, H. Keutmann and C.R. Kahn (1988) A cascade of tyrosine autophosphorylation in the β-subunit activates the insulin receptor. J. Biol. Chem. 263 2969-2980.
12. S.R. Hubbard (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16(18), 5572-5581.
13. K. Nelms, T.J. O'Neill, S. Li, S.R. Hubbard, T.A. Gustafson and W.E. Paul (1999) Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. Mamm. Genome 10(12), 1160-1167.
14. L. Yenush and M.F. White (1997) The IRS-signaling system during insulin and cytokine action. Biol. Essays 19(5), 491-500.
15. T. Pawson and J.D. Scott (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278(5346), 2075-2080.
16. K. Kotani, P. Wilden and T.S. Pillay (1998) SH2-B alpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem. J. 335(pt. 1), 103-109.
17. P. Lock, f. Casagranda and A.R. Dunn (1999) Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck. J. Biol. Chem. 274(32), 22775-22784.
18. T. Noguchi, T. Matozaki, K. Inagaki, M. Tsuda, K. Fukunaga, Y. Kitamura, et al. (1999) Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin, possible role in cell migration. EMBO J. 18(7), 1748-1760.
19. S.H. Chiang, C.A. Baumann, M. Kanzaki, D.C. Thurmond, R.T. Watson, C.L. Neudauer, et al. (2001) Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410(6831), 944-948.
20. C.A. Baumann, V. Ribon, M. Kanzaki, D.C. Thurmond, S. Mora, S. Shigematsu, et al. (2000) CAP defines a second signaling pathway required for insulin-stimulated glucose transport [see comments]. Nature 407(6801), 202-207.
21. D.J. Withers and M.F. White (2000) Perspective: the insulin signaling system—a common link in the pathogenesis of type 2 diabetes. Endocrinology 141(6), 1917-1921.
22. M.J. Eck, S. Dhe-Paganon, T. Trub, R.T. Nolte and S.E. Shoelson (1996) Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85 695-705.
23. T. Uchida, M.G. Myers Jr. and M.F. White (2000) IRS-4 mediates activation of PKB/Akt during insulin stimulation without inhibition of apoptosis. Mol. Cell. Biol. 20(1), 126-138.
24. X. Pin, A.R. Jacobs and S.I. Taylor (1999) Interaction of insulin receptor substrate 3 with insulin receptor, insulin receptor-related receptor, insulin-like growth factor-1 receptor, and downstream proteins. J. Biochem. 274(21), 15262-15270.
25. V.R. Fantin, Q. Wang, G.E. Lienhard and S.R. Keller (2000) Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 278(1), E127-E133.
26. S.C. Liu, Q. Wang, G.E. Lienhard and S.R. Keller (1999) Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J. Biol. Chem. 274(25), 18093-18099.
27. E. Araki, M.A. Lines, M.E. Patti, J.C. Bruning, B. Haag III, R.S. Johnson, et al. (1994) Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372(6502), 186-190.
28. S. Oldham, H. Stocker, M. Laffargue, F. Wittwer, M. Wymann and E. Hafen (2002) The Drosophila insulin/IGF receptor controls growth and size by modulating PtdInsP(3) levels. Development 129(17), 4103-4109.
29. L. Yenush, R. Fernandez, M.G. Myers Jr., T.C. Grammer, X.J. Sun, J. Blenis, et al. (1996) The Drosophila insuling receptor activates multiple signaling pathways but requires IRS-proteins for DNA synthesis. Mol. Cell. Biol. 16(5), 2509-2517.
30. S. Dhe-Paganon, E.A. Ottinger, R.T. Nolte, M.J. Eck and S.E. Shoelson (1999) Crystal structure of the pleckstrin homology-phosphotyrosine binding (P-PTA) targeting region of insulin receptor substrate 1. Proc. Natl. Acad. Sci. USA 96(15), 8378-8383.
31. L. Yenush, K.J. Makati, J. Smith-Hall, O. Ishibashi, M.G. Myers Jr. and M.F. White (1996) The pleckstrin homology domain is the principle link between the insulin receptor and IRS-1. J. Biol. Chem. 271(39), 24300-24306.
32. L. Yenush, C. Zanella, T. Uchida, D. Bernal and M.F. White (1998) The pleckstrin homology and phosphotyrosine biding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin. Mol. Cell. Biol. 18(11), 6784-6794.
33. D.J. Burks, S. Pons, H. Towery, J. Smith-Hall, M.G. Myers Jr., L. Yenush, et al. (1997) Heterologous PH domains do not mediate coupling of IRS-1 to the insulin receptor. J. Biol. Chem. 272(44), 27716-27721.
34. M.A. Lemmon, K.M. Ferguson and J. Schlessinger (1996) PH domains: diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell 85(5), 621-624.
35. D.J. Burks, J. Wang, H. Towery, O. Ishibashi, D. Lowe, H. Riedel, et al. (1998) IRS pleckstrin homology domains bind to acidic motifs in proteins. J. Biol. Chem. 273(47), 3106-31067.
36. J. Farhang-Fallah, X. Yin, G. Trentin, A.M. Cheng and M. Rozakis-Adcock (2000) Cloning and characterization of PHIP, a novel insulin receptor substrate-1 pleckstrin homology domain interacting protein. J. Biol. Chem. 275 40492-40497.
37. E.Y. Skolnik, C.H. Lee, A.G. Batzer, L.M. Vicentini, M. Zhou, R.J. Daly, et al. (1993) The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS-1 and Shc: implications for insulin control of ras signalling. EMBO J. 12 1929-1936.
38. C.R. Weston, D.G. Lambright and R.J. Davis (2002) Signal transduction MAP kinase signaling specificity. Science 296(5577), 2345-2347.
39. Y.T. Ip and R.J. Davis (1998) Signal transduction by the c-Jun N-terminal kinase (JNK): from inflammation to development. Curr. Opin. Cell Biol. 10(2), 205-219.
40. V. Aguirre, E.D. Werner, J. Giraud, Y.H. Lee, S.E. Shoelson and M.F. White (2002) Phosphorylation of ser307 in insulin receptor substrate-1 blocks interactiosn with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277(2), 1531-1537.
41. L. Rui, V. Aguirre, J.K. Kim, G.I. Shulman, A. Lee, A. Corbould, et al. (2001) Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 107(2), 181-189.
42. A.J. Muslin and H. Xing (2000) 14-3-3 proteins, regulation of subcellular localization by molecular interference. Cell Signal 12(11–12), 703-709.
43. T. Ogihara, T. Isobe, T. Ichimura, M. Taoka, M. Funaki and H. Sakada (1997) 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J. Biol. Chem. 272(40), 25267-25274.
44. A. Kosaki, K. Yamada, J. Suga, A. Otaka and H. Kuzuya (1998) 14-3-3 beta protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3′-kinase activity in 3T3L1 adipocytes. J. Biol. Chem. 273(2), 940-944.
45. X. Xiang, M. Yuan, Y. Song, N. Ruderman, R. Wen and Z. Luo (2002) 14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1. Mol. Endocrinol. 16(3), 552-562.
46. D. Sawka-Verhelle, V. Baron, I. Mothe, C. Filloux, M.F. White and E. Van Obberghen (1997) Tyr624 and Tyr628 in insulin receptor substrate-2 mediate its association with the insulin receptor. Am. Soc. Biochem. Mol. Biol. 272(26), 16411-16420.
47. A.R. Saltiel and C.R. Kahn (2001) Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414(6865), 799-806.
48. K. Ueki, C.M. Yballe, S.M. Brachmann, D. Vicent, J.M. Watt, C.R. Kahn, et al. (2002) Increased insuling sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. USA 99(1), 419-424.
49. S. Pons, T. Asano, E.M. Glasheen, M. Miralpeix, Y. Zhang, T.L. Fisher, et al. (1995) The structure and function of p55PIK reveals a new regulatory subunit for the phosphetidylinositol-3 kinase. Mol. Cell. Biol. 15(8), 4453-4465.
50. D.R. Alessi and P. Cohen (1998) Mechanism of activation and function of protein kinase B. Curr. Opin. Gene 8(1), 55-62.
51. A. Brunet, A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96(6), 857-868.
52. K.I. Rother, Y. Imai, M. Caruso, F. Beguinot, P. Formisano and D. Accili (1998) Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J. Biol. Chem. 273(28), 17491-17497.
53. D.A. Fruman, S.B. Snapper, C.M. Yballe, L. Davidson, J.Y. Yu, F.W. Alt, et al. (1999) Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 283(5400), 393-397.
54. K. Ueki, D.A. Fruman, S.M. Brachmann, Y.H. Tseng, L.C. Cantley and C.R. Kahn (2002) Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol. Cell. Biol. 22(3), 965-977.
55. R. Bohni, J. Riesgo-Escovar, S. Oldham, W. Brogiolo, H. Stocker, B.F. Andruss, et al. (1999) Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97(7), 865-875.
56. D.J. Withers, J.S. Gutierrez, H. Towery, D.J. Burks, J.M. Ren, S. Previs, et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391(6670), 900-904.
57. C.S. Carter, M.M. Ramsey and W.E. Sonntag (2002) A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. Trends Genet. 18(6), 295-301.
58. L.M. Wang, A.D. Keegan, W.E. Paul, M.A. Heidaran, J.S. Gutkind and J.H. Pierce (1992) IL-4 activates a distinct signal transduction cascade from IL-3 in factor dependent myeloid cells. EMBO J. 11 4899-4908.
59. L.M. Wang, A.D. Keegan, W. Li, G.E. Lienhard, S. Pacini, J.S. Gutkind, et al. (1993) Common elements in interleukin 4 and insulin signaling pathways in factor dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90 4032-4036.
60. L.M. Wang, M.G. Myers Jr., X.J. Sun, S.A. Aaronson, M.F. White and J.H. Pierce (1993) IRS-1: essential for insulin and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261 1591-1594.
61. X.J. Sun, L.M. Wang, Y. Zhang, L. Yenush, M.G. Myers Jr., E.M. Glasheen, et al. (1995) Role of IRS-2 in insulin and cytokine signaling. Nature 377 173-177.
62. W.E. Paul (1997) Interleukin 4, signaling mechanisms and control of T cell differentiation. Ciba Found. Symp. 204 208-216.
63. K. Nelms, A.D. Keegan, J. Zamorano, J.J. Ryan and W.E. Paul (1999) The IL-4 receptor, signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17 701-738.
64. A.D. Keegan, K. Nelms, M.F. White, L.M. Wang, J.H. Pierce and W.E. Paul (1994) An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76 811-820.
65. A.L. Wurster, D.J. Withers, T. Uchida, M.F. White and M.J. Grusby (2002) Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis. Mol. Cell. Biol. 22(1), 117-126.
66. M.H. Kaplan, C. Daniel, U. Schindler and M.J. Grusby (1998) Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol. Cell. Biol. 18(4), 1996-2003.
67. H. Xiao, T. Yin, X.Y. Wang, T. Uchida, J. Chung, M.F. White, et al. (2002) Specificity of IL-2 receptor gamma chain superfamily cytokines is mediated by insulin receptor substrate-dependent pathway. J. Biol. Chem. (in press)
68. Y. Kido, D.J. Burks, D.J. Withers, J.C. Bruning, C.R. Kahn, M.F. White, et al. (2000) Tissue-specific insulin resistance in mice with mutations of the insulin receptor, IRS-1 and IRS-2. J. Clin. Invest. 105(2), 199-205.
69. E.H. Hani, L. Suaud, P. Boutin, J.C. Chevre, E. Durand, A. Philippi, et al. (1998) A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J. Clin. Invest. 101(3), 521-526.
70. J.M. Carboni, N. Yan, A.D. Cox, X. Bustelo, S.M. Graham, M.J. Lynch, et al. (1995) Farnesyl transferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation. Oncogene 10(10), 1905-1913.
71. M. Vaxillaire, M. Rouard, K. Yamagata, N. Oda, P.J. Kaisaki, V.V. Boriraj, et al. (1997) Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum. Mol. Genet. 6(4), 583-586.
72. D.G. Comb and S. Roseman (1958) Glucosamine metabolism. IV. Glucosamine-6-phosphate deaminase. J. Biol. Chem. 232 807-827.
73. H. Ishihara, T. Sasaoka, H. Hori, T. Wada, H. Hirai, T. Haruta, et al. (1999) Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem. Biophys. Res. Commun. 260(1), 265-272.
74. S. Clement, U. Krause, F. Desmedt, J.-F. Tanti, J. Behrends, X. Pesesse, et al. (2001) The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409 92-97.
75. M. Elchebly, P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A.L. Loy, et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene [see comments]. Science 283(5407), 1544-1548.
76. G.S. Hotamisligil and B.M. Spiegelman (1999) Adipose expression of TNFα: direct role in obesity-linked insulin resistance. Science 259 87-91.
77. G.S. Hotamisligil, P. Peraldi, A. Budvari, R.W. Ellis, M.F. White and B.M. Spiegelman (1996) IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271 665-668.
78. P. Peraldi, G.S. Hotamisligil, W.A. Buurman, M.F. White and B.M. Spiegelman (1996) Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 271(22), 13018-13022.
79. V. Baud and M. Karin (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11(9), 372-377.
80. J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, F.T. Yen, et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 98(4), 2005-2010.
81. M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z.W. Li, M. Karin, et al. (2001) Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293(5535), 1673-1677.
82. J.K. Kim, Y.J. Kim, J.J. Fillmore, Y. Chen, I. Moore, J. Lee, et al. (2001) Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108(3), 437-446.
83. T. Yuasa, S. Ohno, J.H. Kehrl and J.M. Kyriakis (1998) Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273(35), 22681-22692.
84. C.Y. Kuan, D.D. Yang, D.R. Samanta Roy, R.J. Davis, P. Rakic and R.A. Flavell (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22(4), 667-676.
85. M. Rincon, A. Whitmarsh, D.D. Yang, L. Weiss, B. Derijard, P. Jayaraj, et al. (1998) The JNK pathway regulates the in vivo deletion of immature CD4(+)CD8(+) thymocytes. J. Exp. Med. 188(10), 1817-1830.
86. V. Aguirre, T. Uchida, L. Yenush, R.J. Davis and M.F. White (2000) The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J. Biol. Chem. 275(12), 9047-9054.
87. X.J. Sun, J.L. Goldberg, L.Y. Qiao and J.J. Mitchell (1999) Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48(7), 1359-1364.
88. L. Rui, T.L. Fisher, J. Thomas and M.F. White (2001) Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J. Biol. Chem. 276(43), 40362-40367.
89. S. Merforth, A. Osmers and B. Dahlmann (1999) Alterations of proteasome activities in skeletal muscle tissue of diabetic rats. Mol. Biol. Rep. 26(1–2), 83-87.
90. W.E. Mitch, J.L. Bailey, X. Wang, C. Jurkovitz, D. Newby and S.R. Price (1999) Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol. 276 C1132-C1138.
91. G.I. Shulman (2000) Cellular mechanisms of insulin resistance. J. Clin. Invest. 106(2), 171-176.
92. T. Kadowaki, H. Tamemoto, K. Tobe, Y. Terauchi, K. Ueki, Y. Kaburagi, et al. (1996) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 and identification of insulin receptor substrate-2. Diabet. Med. 13(9, suppl. 6), S103-S108.
93. H. Tamemoto, T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, T. Hayakawa, et al. (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372(6502), 182-186.
94. R.N. Kulkarni, J.C. Bruning, J.N. Winnay, C. Postic, M.A. Magnuson and C.R. Kahn (1999) Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell 96(3), 329-339.
95. J.C. Bruning, M.D. Michael, J.N. Winnay, T. Hayashi, D. Horsch, D. Accili, et al. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2(5), 559-569.
96. M.E. Patti, X.J. Sun, J.C. Bruning, E. Araki, M.A. Lipes, M.F. White, et al. (1995) 4PS/IRS-2 is the alternative substrate of the insulin receptor in IRS-1 deficient mice. J. Biol. Chem. 270(42), 24670-24673.
97. T. Yamauchi, K. Tobe, H. Tamemoto, K. Ueki, Y. Kaburagi, R. Yamamoto-Handa, et al. (1996) Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol. Cell. Biol. 16(6), 3074-3084.
98. D.J. Whithers, D.J. Burks, H.H. Towery, S.L. Altamuro, C.L. Flint and M.F. White (1999) Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signaling. Nat. Genet. 23(1), 32-40.
99. S.F. Previs, D.J. Withers, J.M. Ren, M.F. White and G.I. Shulman (2000) Contrasting effects of IRS-1 vs. IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275(50), 38990-38994.
100. D.J. Burks, J.F. de Mora, M. Schubert, D.J. Withers, M.G. Myers, H.H. Towery, et al. (2000) IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407(6802), 377-382.
101. J.A. Kushner, J. Ye, M. Schubert, D.J. Burks, M. Dow, C.L. Flint, et al. (2003) PDX1 restores beta-cell function in IRS-2 knockout mice. J. Clin. Invest. (in press)
102. J. Jonsson, L. Carlsson, T. Edlund and H. Edlund (1994) Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371(6498), 606-609.
103. D.A. Stoffers, N.T. Zinkin, V. Stanojevic, W.L. Clarke and J.F. Habener (1997) Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15(1), 106-110.
104. M.K. Thomas, O.N. Devon, J.H. Lee, A. Peter, D.A. Schlosser, M.S. Tenser, et al. (2001) Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J. Clin. Invest. 108(2), 319-329.
105. U. Ahlgren, J. Jonsson, L. Jonsson, K. Simu and H. Edlund (1998) Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 12(12), 1763-1768.
106. D.A. Stoffers, J. Ferrer, W.L. Clarke and J.F. Habener (1997) Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17(2), 138-139.
107. E.H. Hani, D.A. Stoffers, J.C. Chevre, E. Durand, V. Stanojevic, C. Dina, et al. (1999) Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J. Clin. Invest. 104(9), R41-R48.
108. J.A. Kushner, J. Ye, M. Schubert, D.J. Burks, M.A. Dow, C.L. Flint, et al. (2002) Pdx1 restores beta cell function in Irs2 knockout mice. J. Clin. Invest. 109(9), 1193-1201.